<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00001150</url>
  </required_header>
  <id_info>
    <org_study_id>760293</org_study_id>
    <secondary_id>76-C-0293</secondary_id>
    <nct_id>NCT00001150</nct_id>
  </id_info>
  <brief_title>Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers</brief_title>
  <official_title>Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      The use of a suction blister apparatus has facilitated study of the immunologic capacity of&#xD;
      human epidermal cells. We have been able to prepare purified populations of these cells after&#xD;
      blister formation. Specifically, using the blister tops, we are able to enrich for epidermal&#xD;
      Langerhans cells which are very potent stimulators in antigen presenting assays. Thus, this&#xD;
      normal volunteer study provides an important source of fresh epidermal tissue from which we&#xD;
      can study normal epidermal Langerhans cell function. In addition, we have recently used&#xD;
      blister roofs in important experimental models of HIV-1 transmission. There is no other&#xD;
      method available for assessing the biologic function of freshly isolated Langerhans cells&#xD;
      without altering their milieu. It is a very safe and effective way to obtain human epidermal&#xD;
      samples.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The use of a suction blister apparatus has facilitated study of the immunologic capacity of&#xD;
      human epidermal cells. We have been able to prepare purified populations of these cells after&#xD;
      blister formation. Specifically, using the blister tops, we are able to enrich for epidermal&#xD;
      Langerhans cells which are very potent stimulators in antigen presenting assays. Thus, this&#xD;
      normal volunteer study provides an important source of fresh epidermal tissue from which we&#xD;
      can study normal epidermal Langerhans cell function. In addition, we have recently used&#xD;
      blister roofs in important experimental models of HIV-1 transmission. There is no other&#xD;
      method available for assessing the biologic function of freshly isolated Langerhans cells&#xD;
      without altering their milieu. It is a very safe and effective way to obtain human epidermal&#xD;
      samples.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 1976</start_date>
  <completion_date>March 2004</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <enrollment>2000</enrollment>
  <condition>Dermatitis</condition>
  <condition>Healthy</condition>
  <condition>Neoplasm</condition>
  <condition>Urticaria</condition>
  <condition>Vesiculobullous Skin Disease</condition>
  <eligibility>
    <criteria>
      <textblock>
        INCLUSION CRITERIA&#xD;
&#xD;
        Patients with urticaria of all types, blistering diseases, inflammatory dermatoses and&#xD;
        neoplastic skin diseases.&#xD;
&#xD;
        Patients 18 years of age or older.&#xD;
&#xD;
        No pregnant women.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National Cancer Institute (NCI)</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Blauvelt A, Clerici M, Lucey DR, Steinberg SM, Yarchoan R, Walker R, Shearer GM, Katz SI. Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. J Immunol. 1995 Apr 1;154(7):3506-15.</citation>
    <PMID>7897231</PMID>
  </reference>
  <reference>
    <citation>Blauvelt A, Chougnet C, Shearer GM, Katz SI. Modulation of T cell responses to recall antigens presented by Langerhans cells in HIV-discordant identical twins by anti-interleukin (IL)-10 antibodies and IL-12. J Clin Invest. 1996 Mar 15;97(6):1550-5. doi: 10.1172/JCI118578.</citation>
    <PMID>8617889</PMID>
  </reference>
  <reference>
    <citation>Zaitseva M, Blauvelt A, Lee S, Lapham CK, Klaus-Kovtun V, Mostowski H, Manischewitz J, Golding H. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat Med. 1997 Dec;3(12):1369-75. doi: 10.1038/nm1297-1369.</citation>
    <PMID>9396607</PMID>
  </reference>
  <verification_date>March 2004</verification_date>
  <study_first_submitted>November 3, 1999</study_first_submitted>
  <study_first_submitted_qc>November 3, 1999</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 1999</study_first_posted>
  <last_update_submitted>March 3, 2008</last_update_submitted>
  <last_update_submitted_qc>March 3, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2008</last_update_posted>
  <keyword>Blister Formation</keyword>
  <keyword>Inflammatory Mediator Assay</keyword>
  <keyword>Ultraviolet Radiation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Urticaria</mesh_term>
    <mesh_term>Skin Diseases</mesh_term>
    <mesh_term>Blister</mesh_term>
    <mesh_term>Skin Diseases, Vesiculobullous</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

